New EPO Patent Insight Report: mRNA Technologies and Patents

European Patent Office (EPO) just published the ninth patent insight report, providing an overview of important patent trends in the field of mRNA-based vaccines, which is a particularly dynamic sub-area of mRNA technologies. The report is also the second report related to the medical sector.

The report presents the findings of patent analyses that were conducted through collaboration between subject-matter specialists and patent knowledge experts at the EPO. In this study, publicly accessible patent data sourced from the EPO's databases of global patent information was examined. Patent data is a valuable resource of technical knowledge concerning inventions for which applicants sought patent protection, driven by their commercial aspirations. Patent information frequently contains technical details and other information that may not be accessible from any other information source.

The report finds that the number of inventions in the field of mRNA-based vaccines multiplied over the last decade and showed higher growth rate than across all fields of technology in general.

According to the findings, The most active applicants in the field of mRNA-based vaccines are companies and universities based in the United States, Europe and China.